कैंसर अनुसंधान में पुरालेख

  • आईएसएसएन: 2254-6081
  • जर्नल एच-इंडेक्स: 13
  • जर्नल उद्धरण स्कोर: 3.58
  • जर्नल प्रभाव कारक: 3.12
में अनुक्रमित
  • चीन राष्ट्रीय ज्ञान अवसंरचना (सीएनकेआई)
  • उद्धरण कारक
  • ओसीएलसी- वर्ल्डकैट
  • पबलोन्स
  • चिकित्सा शिक्षा और अनुसंधान के लिए जिनेवा फाउंडेशन
  • गूगल ज्ञानी
  • गुप्त खोज इंजन लैब्स
इस पृष्ठ को साझा करें

अमूर्त

Recent Developments and the Use of "Real-Time Liquid Biopsy" with Circulating Tumour Cells in Ovarian Cancer

Wilson Steve

An abnormal mass of tissue that forms once cells grow and divide quite ought to they ought to they must} or don't die once they should. Tumors could also be benign (not cancer) or malignant (cancer). Benign tumors could grow however don't unfold into, or invade, near tissues or alternative components of the body. Malignant tumors will unfold into, or invade, near tissues. They will conjointly unfold to alternative components of the body through the blood and liquid body substance systems conjointly known as tumor. Even with the most recent advances in technology, the treatment of gonad cancer remains an enormous challenge as a result of it's usually diagnosed at advanced stage, is at risk of early relapse in spite of aggressive treatment and has an especially poor prognosis. Current growth cells (CTCs) are often used as a non-invasive “real-time liquid biopsy”, that has shown the worth of diagnosing, assessment of prognosis and chemo resistance, and detection of tiny residual tumors on gonad cancer. This critique provides a summary on recent analysis on CTCs in gonad cancer, with special specialize in the clinical application of CTC tests.

Keywords: Circulating tumor cells; Liquid biopsy; Microfluidics Ovarian cancer; Cancer research; Tumor; Gonad cancer